Ketone Bodies as Anti-Seizure Agents

Neurochemical Research

Volumn 42, Issue 7, 2017, Pages 2011-2018

  Simeone, Timothy A ^a   Simeone, Kristina A ^a   Rho, Jong M ^b,c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Acetoacetate; Beta hydroxybutyrate; Epilepsy; Ketogenic diet; Ketone bodies; Neuroprotection

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; ACETOACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ANTICONVULSIVE AGENT; HISTONE DEACETYLASE; HYDROXYCARBOXYLIC ACID RECEPTOR; INFLAMMASOME; KETONE BODY; PROTEIN NRLP3; RECEPTOR; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER; HISTONE DEACETYLASE INHIBITOR;

AMINO ACID SYNTHESIS; ARTICLE; ENZYME INHIBITION; EPILEPSY; FATTY ACID OXIDATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KETOGENESIS; KETOGENIC DIET; MITOCHONDRIAL PERMEABILITY; MOLECULARLY TARGETED THERAPY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; DIET THERAPY; DRUG EFFECTS; METABOLISM; PROCEDURES; SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN; DIET, KETOGENIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; KETONE BODIES; SEIZURES;

EID: 85017258389     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-017-2253-5     Document Type: Article

References (64)

1. Chang BS, Lowenstein DH (2003) Epilepsy. N Engl J Med 349:1257–1266
2. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319
3. Kanner AM (2016) Management of psychiatric and neurological comorbidities in epilepsy. Nat Rev Neurol 12:106–116
4. Wheless JW (2008) History of the ketogenic diet. Epilepsia 49(Suppl 8):3–5
5. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM (1998) The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102:1358–1363
6. Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E (2006) The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Res 68:145–180
7. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 7:500–506
8. Lambrechts DA, de Kinderen RJ, Vles JS, de Louw AJ, Aldenkamp AP, Majoie HJ (2017) A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand 135:231–239
9. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH (2009) A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50:1109–1117
10. Rogawski MA, Loscher W, Rho JM (2016) Mechanisms of action of antiseizure drugs and the ketogenic diet. Cold Spring Harb Perspect Med. doi:10.1101/cshperspect.a022780
11. van Delft R, Lambrechts D, Verschuure P, Hulsman J, Majoie M (2010) Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure 19:36–39
12. Gilbert DL, Pyzik PL, Freeman JM (2000) The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J Child Neurol 15:787–790
13. Pfeifer HH, Thiele EA (2005) Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 65:1810–1812
14. Morris AA (2005) Cerebral ketone body metabolism. J Inherit Metab Dis 28:109–121
15. Kim DY, Rho JM (2008) The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care 11:113–120
16. Keith HM (1933) Factors influencing experimentally produced convulsions. Arch Neurol Psychiatry 29:148–154
17. Keith HM (1935) Experimental convulsions induced by administration of thujone. Arch Neur Psych 34:1022–1040
18. Keith HM (1932) Further studies of the control of experimentally produced convulsions. Pharmacol Exp Ther 44:449–455
19. Keith HM (1931) The effect of various factors on experimentally produced convulsions. Am J Dis Child 41:532–543
20. Rho JM, Anderson GD, Donevan SD, White HS (2002) Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43:358–361
21. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC 3rd, Burnham WM (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol 54:219–226
22. Likhodii SS, Burnham WM (2002) Ketogenic diet: does acetone stop seizures? Med Sci Monit 8:Hy19–24
23. Minlebaev M, Khazipov R (2011) Antiepileptic effects of endogenous beta-hydroxybutyrate in suckling infant rats. Epilepsy Res 95:100–109
24. Yum MS, Lee M, Woo DC, Kim DW, Ko TS, Velisek L (2015) beta-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy. Epilepsy Res 117:125–132
25. Kim DY, Simeone KA, Simeone TA, Pandya JD, Wilke JC, Ahn Y, Geddes JW, Sullivan PG, Rho JM (2015) Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol 78:77–87
26. Thavendiranathan P, Mendonca A, Dell C, Likhodii SS, Musa K, Iracleous C, Cunnane SC, Burnham WM (2000) The MCT ketogenic diet: effects on animal seizure models. Exp Neurol 161:696–703
27. D’Agostino DP, Pilla R, Held HE, Landon CS, Puchowicz M, Brunengraber H, Ari C, Arnold P, Dean JB (2013) Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am J Physiol Regul Integr Comp Physiol 304:R829–R836
28. Viggiano A, Pilla R, Arnold P, Monda M, D’Agostino D, Zeppa P, Coppola G (2016) Different calorie restriction treatments have similar anti-seizure efficacy. Seizure 35:45–49
29. Viggiano A, Pilla R, Arnold P, Monda M, D’Agostino D, Coppola G (2015) Anticonvulsant properties of an oral ketone ester in a pentylenetetrazole-model of seizure. Brain Res 1618:50–54
30. Yang L, Zhao J, Milutinovic PS, Brosnan RJ, Eger EI 2nd, Sonner JM (2007) Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone. Anesthes analg 105:673–679
31. Thio LL, Wong M, Yamada KA (2000) Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54:325–331
32. Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J, Ishii E (2009) Beta-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res 1268:17–23
33. Erecinska M, Nelson D, Daikhin Y, Yudkoff M (1996) Regulation of GABA level in rat brain synaptosomes: fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J Neurochem 67:2325–2334
34. Daikhin Y, Yudkoff M (1998) Ketone bodies and brain glutamate and GABA metabolism. Dev Neurosci 20:358–364
35. Zhang Y, Zhang S, Marin-Valencia I, Puchowicz MA (2015) Decreased carbon shunting from glucose toward oxidative metabolism in diet-induced ketotic rat brain. J Neurochem 132:301–312
36. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2001) Brain amino acid metabolism and ketosis. J Neurosci Res 66:272–281
37. Valente-Silva P, Lemos C, Kofalvi A, Cunha RA, Jones JG (2015) Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices. NMR Biomed 28:1111–1116
38. Lund TM, Obel LF, Risa O, Sonnewald U (2011) Beta-hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons. Neurochem Int 59:309–318
39. Lund TM, Risa O, Sonnewald U, Schousboe A, Waagepetersen HS (2009) Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons. J Neurochem 110:80–91
40. Ma W, Berg J, Yellen G (2007) Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J Neurosci 27:3618–3625
41. Tanner GR, Lutas A, Martinez-Francois JR, Yellen G (2011) Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons. J Neurosci 31:8689–8696
42. Kim DY, Vallejo J, Rho JM (2010) Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem 114:130–141
43. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr (1978) Chronic ketosis and cerebral metabolism. Ann Neurol 3:331–337
44. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60:223–235
45. Kawamura M Jr, Ruskin DN, Masino SA (2010) Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels. J Neurosci 30:3886–3895
46. Munster-Wandowski A, Zander JF, Richter K, Ahnert-Hilger G (2016) Co-existence of functionally different vesicular neurotransmitter transporters. Front Synaptic Neurosci 8:4
47. Omote H, Miyaji T, Juge N, Moriyama Y (2011) Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. BioChemistry 50:5558–5565
48. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y (2010) Metabolic control of vesicular glutamate transport and release. Neuron 68:99–112
49. Maalouf M, Sullivan PG, Davis L, Kim DY, Rho JM (2007) Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145:256–264
50. Maalouf M, Rho JM (2008) Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2 A and is prevented by ketone bodies. J Neurosci Res 86:3322–3330
51. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE (2005) Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res 79:231–239
52. Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L (2016) Mitochondrial permeability transition: new findings and persisting uncertainties. Trends Cell Biol 26:655–667
53. Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32–42
54. Huberfeld G, Vecht CJ (2016) Seizures and gliomas-towards a single therapeutic approach. Nat Rev Neurol 12:204–216
55. Damaskos C, Valsami S, Kontos M, Spartalis E, Kalampokas T, Kalampokas E, Athanasiou A, Moris D, Daskalopoulou A, Davakis S, Tsourouflis G, Kontzoglou K, Perrea D, Nikiteas N, Dimitroulis D (2017) Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer. Anticancer Res 37:35–46
56. Monti B, Polazzi E, Contestabile A (2009) Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol 2:95–109
57. Loscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16:669–694
58. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E (2013) Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211–214
59. Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Muller-Fielitz H, Pokorna B, Vollbrandt T, Stolting I, Nadrowitz R, Okun JG, Offermanns S, Schwaninger M (2014) The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5:3944
60. Vezzani A, Lang B, Aronica E (2015) Immunity and inflammation in epilepsy. Cold Spring Harb Perspect Med 6:a022699
61. Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D’Agostino D, Planavsky N, Lupfer C, Kanneganti TD, Kang S, Horvath TL, Fahmy TM, Crawford PA, Biragyn A, Alnemri E, Dixit VD (2015) The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21:263–269
62. Bae HR, Kim DH, Park MH, Lee B, Kim MJ, Lee EK, Chung KW, Kim SM, Im DS, Chung HY (2016) Beta-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation. Oncotarget 7:66444–66454
63. Kobow K, Kaspi A, Harikrishnan KN, Kiese K, Ziemann M, Khurana I, Fritzsche I, Hauke J, Hahnen E, Coras R, Muhlebner A, El-Osta A, Blumcke I (2013) Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 126:741–756
64. Nabbout R, Mazzuca M, Hubert P, Peudennier S, Allaire C, Flurin V, Aberastury M, Silva W, Dulac O (2010) Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 51:2033–2037